%PDF-1.6
%
7 0 obj
<>
endobj
13 0 obj
<>/Filter/FlateDecode/ID[<6AB61FCA5FF243C19EC834F0BB8A2B03><275DBE6633E846B8996DD161A12BA739>]/Index[7 8]/Info 6 0 R/Length 40/Prev 2960094/Root 8 0 R/Size 15/Type/XRef/W[1 2 0]>>stream
hbbd`b`gb`ab`
|01lp ,n
endstream
endobj
startxref
0
%%EOF
14 0 obj
<>stream
hb```a``+eǀ X8Px dQ03j@
endstream
endobj
8 0 obj
<>
endobj
9 0 obj
<>>>/Rotate 0/Type/Page>>
endobj
10 0 obj
<>stream
q
595.1999969 0 0 841.9199982 0 0 cm
/Im0 Do
Q
endstream
endobj
11 0 obj
<>stream
Adobe Photoshop 22.3 (Macintosh)
2021-04-15T10:25:22+02:00
2021-06-11T09:20:26+02:00
2021-06-11T09:20:26+02:00
image/jpeg
xmp.iid:717519a0-ce2c-4a09-abc6-78e549742a9f
adobe:docid:photoshop:c4f6a09e-fb28-7141-b728-11525bb3c9b5
xmp.did:f0ead3b3-bb35-4cc1-950c-b66c4f989c02
created
xmp.iid:f0ead3b3-bb35-4cc1-950c-b66c4f989c02
2021-04-15T10:25:22+02:00
Adobe Photoshop 22.3 (Macintosh)
saved
xmp.iid:c391129e-7c35-4069-9dcb-9d51eb526e05
2021-04-16T09:51:07+02:00
Adobe Photoshop 22.3 (Macintosh)
/
saved
xmp.iid:d0efc833-4617-4ac3-82f7-30e18c55626b
2021-06-11T09:20:26+02:00
Adobe Photoshop 22.4 (Macintosh)
/
converted
from application/vnd.adobe.photoshop to image/jpeg
derived
converted from application/vnd.adobe.photoshop to image/jpeg
saved
xmp.iid:717519a0-ce2c-4a09-abc6-78e549742a9f
2021-06-11T09:20:26+02:00
Adobe Photoshop 22.4 (Macintosh)
/
xmp.iid:d0efc833-4617-4ac3-82f7-30e18c55626b
adobe:docid:photoshop:3f7f0f3d-a0ff-d045-9dce-758b7ec12475
xmp.did:f0ead3b3-bb35-4cc1-950c-b66c4f989c02
3
WHY FRANCE ?
WHY FRANCE ?
For more information: contact@afcros.com | www.afcros.com
For more information: contact@afcros.com | www.afcros.com
www.afcros.com copie
www.afcros.com
Clinical research
Clinical research
Medical excellence
Medical excellence
+ Several scientific academic societies + International reputat
+ Several scientific academic societies + International reputation of our KOLs + Large patient advocacy groups led by experts patients + Oncology & Rare Disease: top French expertise Oncology + 45% of French Industrial Trials (versus 25% in Europe) + 16 labelled centres for cancer early-phase (INCa-CLIP) + Unique Oncology Network (public or private centers) such as Centre Léon Bérard, Institut Curie, Institut Gustave Roussy… Rare Disease + 8 out of 24 European Reference Network for addressing patients to specialized centre + 109 expertise centres for diagnostic and treatment of rare disease + Public and Private commitment in Rare Diseases research: 3rd French governmental plan for 2018-22
Business Processes Enablers
Business Processes Enablers
Regulatory Authority (ANSM) Central Ethi
Regulatory Authority (ANSM) Central Ethic Committee (CPP) Clinical Trial Agreement template for all hospitals (Fully executed in 45 days) + Pilot Phase: in preparation of EU Clinical Trials regulation + Fast-Track Processes: accelerated authorizations for Investigational Products + More than 30 years’ experience for Early Access programme (EAP) + EUCROF leader for EU Code of Conduct design with CNIL (French Data Protection Authority) as reference body + Research Tax Credit = 30% for R&D expenditures
One
One
40 DAYS
40 DAYS
21 DAYS
21 DAYS
WITH QUESTIONS
WITH QUESTIONS
WITHOUT
WITHOUT
FAST TRACK 1 - Innovative treatments
FAST TRACK 1 - Innovative treatments
25 DAYS
25 DAYS
14 DAYS
14 DAYS
WITH QUESTIONS
WITH QUESTIONS
WITHOUT
WITHOUT
FAST TRACK 2 - Drugs already known
FAST TRACK 2 - Drugs already known
Operational excellence
Operational excellence
+ AFCROs is the largest member of EUCROF with 90 French compani
+ AFCROs is the largest member of EUCROF with 90 French companies + Health Data Hub: Unique Public Database about French health data (+66M patients) + Active academic network (F-CRIN) and Public structures (CNCR) to enforce & coordinate Clinical Research + Fully trained professional by recognized courses; Internationally specialized courses (Pharmaco-epidemiology, Real World Data)
Consumption of care and medical goods
Consumption of care and medical goods
200B€
200B€
GDP
GDP
8,6%
8,6%
Physicians
Physicians
200K
200K
Healthcare institutions
Healthcare institutions
3 000
3 000
Cancer: new patients/year
Cancer: new patients/year
400K
400K
Inhabitants suffering from rare diseases
Inhabitants suffering from rare diseases
3M
3M
Neurology and vascular: stroke/year
Neurology and vascular: stroke/year
150K
150K
Pain management: patients treated/year
Pain management: patients treated/year
227K
227K
of consumption of care and medical goods
of consumption of care and medical goods
200B€
200B€
of GDP
of GDP
8,6%
8,6%
physicians
physicians
200K
200K
healthcare institutions
healthcare institutions
3 000
3 000
cancer: new patients/year
cancer: new patients/year
400K
400K
habitants suffering from rare diseases
habitants suffering from rare diseases
3M
3M
neurology and vascular: stroke/year
neurology and vascular: stroke/year
150K
150K
Pain management: patients treated/year
Pain management: patients treated/year
227K
227K
France, an EU leader in healthcare
France, an EU leader in healthcare
43B2D564B25BBD9389136BB6724CA21F
491812AAF77E763FE9E7AACD2CF479CC
adobe:docid:photoshop:b28c97d7-751c-0446-93f0-1d673689d9c0
256
3234213120/270991360
3234213120/270991360
512
65535
2953379840
3020750848
endstream
endobj
12 0 obj
<>stream
JFIF Exif MM * b j( 1 ! r2 i - ' - 'Adobe Photoshop 22.4 (Macintosh) 2021:06:11 09:20:26
" *( 2 x H H Adobe_CM Adobe d
q" ?
3 !1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw 5 !1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ? ]6g͎fSޕl3 X=bOzvMas n,\rg
i#aaݝZ#ֱ54{]?W6V85D*jp}v7s^[Z7znŮk5K5ro6om j)@)Yc*ҍYN>9T:m6sܣ?C}~]ۺANCi//4zczOzz`"#''>Lu86ͧ5Uf^[]YY o՞K2{,n-.4P_w+']v+Zm귛bP[N/mm}?g__h`55Xe5j;;-{ ,[% z[3QuĢP{>vX,6e{};+Ur5;;&*tRŚzS M WXzhcpp:s\Z̏7~-7;fd5̷/X__ su6βF!=u$ 6~ح^K/cm>Uo%/U۟^V݈>sB,g}ctɹ6 Ml 'U 3&,#J#̮;RNiT^L_U}u4졯?1LuHewٜ}0kc;V{,'H$J||쾦Z{C%wq鸍:)h!3![nkcs^XX